Jones Christy 4
4 · Beta Bionics, Inc. · Filed Feb 3, 2025
Insider Transaction Report
Form 4
Jones Christy
Director
Transactions
- Award
Director Stock Option (right to buy)
2025-01-31+48,730→ 48,730 totalExercise: $7.51Exp: 2032-07-26→ Common Stock (48,730 underlying) - Award
Director Stock Option (right to buy)
2025-01-31+9,137→ 9,137 totalExercise: $7.51Exp: 2031-12-07→ Common Stock (9,137 underlying) - Award
Director Stock Option (right to buy)
2025-01-31+9,137→ 9,137 totalExercise: $7.51Exp: 2031-12-07→ Common Stock (9,137 underlying)
Footnotes (4)
- [F1]The shares subject to this option shall vest in 36 equal monthly installments measured from April 27, 2021.
- [F2]Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.
- [F3]The shares subject to this option shall vest in 36 equal monthly installments measured from July 20, 2021.
- [F4]The shares subject to this option shall vest in 48 equal monthly installments measured from July 27, 2022.